| [1] | 
																						 
											  HIRSCH F R,, SCAGLIOTTI G V,, MULSHINE J L, et al. Lung cancer: current therapies and new targeted treatments[J]. Lancet, 2017, 389(10066): 299-311. 
											 												 
																									doi: 10.1016/S0140-6736(16)30958-8
																																			 											 | 
										
																													
																						| [2] | 
																						 
											  SIEGEL R L,, MILLER K D,, JEMAL A. Cancer statistics, 2018[J]. CA A Cancer J Clin, 2018, 68(1): 7-30. 
											 												 
																									doi: 10.3322/caac.21442
																																			 											 | 
										
																													
																						| [3] | 
																						 
											  OLIVEIRA M B,, MELLO F C,, PASCHOAL M E M. The relationship between lung cancer histology and the clinicopathological characteristics of bone metastases[J]. Lung Cancer, 2016, 96: 19-24. 
											 												 
																									doi: 10.1016/j.lungcan.2016.03.014
																																			 											 | 
										
																													
																						| [4] | 
																						 
											  LI S L,, PENG Y,, WEINHANDL E D, et al. Estimated number of prevalent cases of metastatic bone disease in the US adult population[J]. Clin Epidemiol, 2012, 4: 87-93.
											 											 | 
										
																													
																						| [5] | 
																						 
											  DUNNE E M,, FRASER I M,, LIU M. Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions[J]. Ann Transl Med, 2018, 6(14): 283. 
											 												 
																									doi: 10.21037/atm.2018.06.40
																																			 											 | 
										
																													
																						| [6] | 
																						 
											  HAMIDI H,, IVASKA J. Every step of the way: integrins in cancer progression and metastasis[J]. Nat Rev Cancer, 2018, 18(9): 533-548. 
											 												 
																									doi: 10.1038/s41568-018-0038-z
																																			 											 | 
										
																													
																						| [7] | 
																						 
											  DAS V,, KALYAN G,, HAZRA S, et al. Understanding the role of structural integrity and differential expression of integrin profiling to identify potential therapeutic targets in breast cancer[J]. J Cell Physiol, 2018, 233(1): 168-185. 
											 												 
																									doi: 10.1002/jcp.25821
																																			 											 | 
										
																													
																						| [8] | 
																						 
											  SWITALA-JELEN K,, DABROWSKA K,, OPOLSKI A, et al. The biological functions of beta3 integrins[J]. Folia Biol (Praha), 2004, 50(5): 143-152.
											 											 | 
										
																													
																						| [9] | 
																						 
											  ROBINSON S D,, HODIVALA-DILKE K M. The role of β3-integrins in tumor angiogenesis: context is everything[J]. Curr Opin Cell Biol, 2011, 23(5): 630-637. 
											 												 
																									doi: 10.1016/j.ceb.2011.03.014
																																			 											 | 
										
																													
																						| [10] | 
																						 
											  WEILBAECHER K N,, GUISE T A,, MCCAULEY L K. Cancer to bone: a fatal attraction[J]. Nat Rev Cancer, 2011, 11(6): 411-425. 
											 												 
																									doi: 10.1038/nrc3055
																																			 											 | 
										
																													
																						| [11] | 
																						 
											  CARTER R Z,, MICOCCI K C,, NATOLI A, et al. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer[J]. J Pathol, 2015, 235(5): 760-772. 
											 												 
																									doi: 10.1002/path.4490
																																			 											 | 
										
																													
																						| [12] | 
																						 
											  GU H B,, SUN L,, DOU Z W, et al. Analysis of lung adenocarcinoma with bone metastasis: a case report[J]. Transl Lung Cancer Res, 2020, 9(2): 389-392. 
											 												 
																									doi: 10.21037/tlcr.2020.03.11
																																			 											 | 
										
																													
																						| [13] | 
																						 
											  北京医学奖励基金会肺癌青年专家委员会, 中国胸外科肺癌联盟.  肺癌骨转移诊疗专家共识(2019版)[J]. 中国肺癌杂志, 2019, 22(4): 187-207.
											 											 | 
										
																													
																						 | 
																						 
											  The Youth Specialists Committee of Lung Cancer of Beijing Medical Award Foundaton, Chinese Lung Cancer Union.  Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer(2019 version)[J]. Chin J Lung Cancer, 2019, 22(4): 187-207.
											 											 | 
										
																													
																						| [14] | 
																						 
											  ZHANG N,, MA D N,, WANG L, et al. Insufficient radiofrequency ablation treated hepatocellular carcinoma cells promote metastasis by up-regulation ITGB3[J]. J Cancer, 2017, 8(18): 3742-3754. 
											 												 
																									doi: 10.7150/jca.20816
																																			 											 | 
										
																													
																						| [15] | 
																						 
											  BOULEFTOUR W,, JUIGNET L,, BOUET G, et al. The role of the SIBLING, bone sialoprotein in skeletal biology-contribution of mouse experimental genetics[J]. Matrix Biol, 2016, 52/53/54: 60-77.
											 											 | 
										
																													
																						| [16] | 
																						 
											  SLOAN E K,, POULIOT N,, STANLEY K L, et al. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone[J]. Breast Cancer Res, 2006, 8(2): R20. 
											 												 
																									doi: 10.1186/bcr1398
																																			 											 | 
										
																													
																						| [17] | 
																						 
											  BAKEWELL S J,, NESTOR P,, PRASAD S, et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis[J]. Proc Natl Acad Sci USA, 2003, 100(24): 14205-14210. 
											 												 
																									doi: 10.1073/pnas.2234372100
																																			 											 |